Searching across hundreds of databases
Nicotine, the main addictive component of tobacco, promotes body weight reduction in humans and rodents. Recent evidence has suggested that nicotine acts in the central nervous system to modulate energy balance. Specifically, nicotine modulates hypothalamic AMP-activated protein kinase to decrease feeding and to increase brown adipose tissue thermogenesis through the sympathetic nervous system, leading to weight loss. Of note, most of this evidence has been obtained in animal models fed with normal diet or low-fat diet (LFD). However, its effectiveness in obese models remains elusive. Because obesity causes resistance towards many factors involved in energy homeostasis, the aim of this study has been to compare the effect of nicotine in a diet-induced obese (DIO) model, namely rats fed a high-fat diet, with rats fed a LFD. Our data show that chronic peripheral nicotine treatment reduced body weight by decreasing food intake and increasing brown adipose tissue thermogenesis in both LFD and DIO rats. This overall negative energy balance was associated to decreased activation of hypothalamic AMP-activated protein kinase in both models. Furthermore, nicotine improved serum lipid profile, decreased insulin serum levels, as well as reduced steatosis, inflammation, and endoplasmic reticulum stress in the liver of DIO rats but not in LFD rats. Overall, this evidence suggests that nicotine diminishes body weight and improves metabolic disorders linked to DIO and might offer a clear-cut strategy to develop new therapeutic approaches against obesity and its metabolic complications.
Pubmed ID: 24517227 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets FASN
View all literature mentionsThis polyclonal targets PSMD9
View all literature mentionsThis polyclonal targets phospho-Acetyl CoA Carboxylase (Ser79)
View all literature mentionsThis polyclonal targets AMP-Activated Protein Kinase (AMPK) alpha 1
View all literature mentionsThis polyclonal targets AMP-Activated Protein Kinase (AMPK) alpha 2
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets AMPK-alpha, phospho (Thr172)
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis polyclonal targets EIF2S1
View all literature mentionsThis monoclonal targets Acetyl CoA Carboxylase 1 Rabbit mAb
View all literature mentionsThis polyclonal targets XBP-1 (M-186)
View all literature mentionsThis recombinant monoclonal targets IRE1-alpha
View all literature mentionsThis polyclonal targets IRE1 (phospho S724)
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
